Imiquimod Enhances IFN-γ Production and Effector Function of T Cells Infiltrating Human Squamous Cell Carcinomas of the Skin
- 1 November 2009
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (11) , 2676-2685
- https://doi.org/10.1038/jid.2009.151
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsThe Journal of Experimental Medicine, 2008
- Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patientsBritish Journal of Dermatology, 2007
- T-Cell Distribution and Adhesion Receptor Expression in Metastatic MelanomaClinical Cancer Research, 2007
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinomaJournal of the American Academy of Dermatology, 2006
- Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Imiquimod: An Effective Alternative for the Treatment of Invasive Cutaneous Squamous Cell CarcinomaDermatologic Surgery, 2006
- Skin Cancers after Organ TransplantationNew England Journal of Medicine, 2003
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002